NIH-funded research R15 grant

Understanding how certain proteins regulate cellular functions through redox mechanisms

Official title: Mechanistic characterizations of redox regulations and functions of Arf and Rho families

Funded at University of Texas Arlington · NIH-11036628 · Data updated 2026-11-12

This study is looking at how certain proteins in our cells, called Arf and Rho, work and change when they encounter different conditions, with the hope of finding new ways to treat diseases related to these proteins.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$26,084
NIH project number3R15GM152973-01S1
Project IDNIH-11036628 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with immune system disorders or diseases related to cellular dysfunction.

Less likely to help

Patients with conditions unrelated to immune dysfunction or cellular processes may not benefit from this research.

What this research studies

This research investigates the roles of Arf and Rho small GTPases, which are essential for various cellular functions. The study aims to uncover how these proteins are regulated by redox-sensitive motifs, which are currently not well understood. By employing advanced techniques such as EPR and mass spectrometry, the researchers will explore the interactions and transformations of these proteins in response to redox changes. The ultimate goal is to identify new therapeutic strategies for diseases linked to these proteins by developing novel nucleotide analogs that can modulate their activity.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments for diseases associated with immune dysfunction and other disorders linked to Arf and Rho proteins.

How similar studies have gone: While the specific approach of targeting redox-sensitive motifs in Arf and Rho proteins is novel, similar studies have shown promise in understanding protein functions and developing therapeutics.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: Heo, Jongyun — University of Texas Arlington
  • Study coordinator: Heo, Jongyun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.